Желтая лихорадка

Список литературы

Основные статьи

Monath TP. Yellow fever: an update. Lancet Infect Dis. 2001;1:11-20. Аннотация

World Health Organization. Vaccines and vaccination against yellow fever. WHO position paper - June 2013. Wkly Epidemiol Rec. 2013;88:269-284.Полный текст  Аннотация

Staples JE, Bocchini JA Jr, Rubin L; Centers for Disease Control and Prevention (CDC). Yellow fever vaccine booster doses: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:647-650.Полный текст  Аннотация

Gotuzzo E, Yactayo S, Córdova E. Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. Am J Trop Med Hyg. 2013;89:434-444. Аннотация

Pan American Health Organization; World Health Organization. Laboratory diagnosis of yellow fever virus infection. September 2018 [internet publication].Полный текст

Статьи, указанные как источники

1. Barnett ED. Yellow fever: epidemiology and prevention. Clin Infect Dis. 2007;44:850-856.Полный текст  Аннотация

2. Monath TP. Yellow fever: an update. Lancet Infect Dis. 2001;1:11-20. Аннотация

3. World Health Organization. Vaccines and vaccination against yellow fever. WHO position paper - June 2013. Wkly Epidemiol Rec. 2013;88:269-284.Полный текст  Аннотация

4. World Health Organization. Disease outbreak news. Yellow fever - Mali. December 2019 [internet publication].Полный текст

5. World Health Organization. Disease outbreak news. Yellow fever - Nigeria. December 2017 [internet publication].Полный текст

6. World Health Organization. Disease outbreak news. Yellow fever - Nigeria. December 2019 [internet publication].Полный текст

7. World Health Organization. Winning the war against yellow fever. November 2016 [internet publication].Полный текст

8. World Health Organization. Weekly epidemiological record. Yellow fever in Africa and the Americas, 2017. August 2018 [internet publication].Полный текст

9. Wilder-Smith A, Monath TP. Responding to the threat of urban yellow fever outbreaks. Lancet Infect Dis. 2017;17:248-250.Полный текст  Аннотация

10. Centers for Disease Control and Prevention (CDC). Health information for international travel (Yellow Book). Chapter 4: travel-related infectious diseases, Yellow fever. August 2019 [internet publication].Полный текст

11. World Health Organization. Yellow fever in the WHO African and American Regions, 2010. Wkly Epidemiol Rec. 2011;86:370-376.Полный текст  Аннотация

12. World Health Organization: Global Response and Alert (GAR). Yellow fever: a current threat. 2017 [internet publication].Полный текст

13. Vasconcelos PF, Costa ZG, Travassos da Rosa ES, et al. Epidemic of jungle yellow fever in Brazil, 2000: implications of climatic alterations in disease spread. J Med Virol. 2001;65:598-604. Аннотация

14. Franz DR, Jahrling PB, Friedlander AM, et al. Clinical recognition and management of patients exposed to biological warfare agents. JAMA. 1997;278:399-411. Аннотация

15. Advisory Committee on Immunization Practices (ACIP). General recommendations on immunization - recommendations of the ACIP. MMWR Recomm Rep. 2011;60:1-64.Полный текст  Аннотация

16. Centers of Disease Control and Prevention. Fatal yellow fever in a traveler returning from Amazonas, Brazil, 2002. MMWR Morb Mortal Wkly Rep. 2002;51:324-325.Полный текст  Аннотация

17. Cornet JP, Huard M, Camicas JL, et al. Experimental transmission of the yellow fever virus by the tick Amblyomma variegatum (F.). Bull Soc Pathol Exot Filiales. 1982;75:136-140. Аннотация

18. Staples JE, Bocchini JA Jr, Rubin L; Centers for Disease Control and Prevention (CDC). Yellow fever vaccine booster doses: recommendations of the Advisory Committee on Immunization Practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64:647-650.Полный текст  Аннотация

19. World Health Organization. Updates on yellow fever vaccination recommendations for international travelers related to the current situation in Brazil. May 2018 [internet publication].Полный текст

20. Gotuzzo E, Yactayo S, Córdova E. Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. Am J Trop Med Hyg. 2013;89:434-444. Аннотация

21. Grobusch MP, Goorhuis A, Wieten RW, et al. Yellow fever revaccination guidelines change - a decision too feverish? Clin Microbiol Infect. 2013;19:885-886. Аннотация

22. World Health Organization Department of Immunization, Vaccines and Biologicals. Fractional dose yellow fever vaccine as a dose-sparing option for outbreak response. July 2016 [internet publication].Полный текст

23. Casey RM, Harris JB, Ahuka-Mundeke S, et al. Immunogenicity of fractional-dose vaccine during a yellow fever outbreak - final report. N Engl J Med. 2019 Aug 1;381(5):444-454.Полный текст  Аннотация

24. Roukens AHE, van Halem K, de Visser AW, et al. Long-term protection after fractional-dose yellow fever vaccination: follow-up study of a randomized, controlled, noninferiority trial. Ann Intern Med. 2018 Nov 27 [Epub ahead of print]. Аннотация

25. Thomas RE, Lorenzetti DL, Spragins W, et al. Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review. Vaccine. 2011;29:4544-4555. Аннотация

26. Farez MF, Correale J. Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis. Arch Neurol. 2011;68:1267-1271. Аннотация

27. Traiber C, Coelho-Amaral P, Ritter VR, et al. Infant meningoencephalitis caused by yellow fever vaccine virus transmitted via breastmilk. J Pediatr (Rio J). 2011;87:269-272. Аннотация

28. Barte H, Horvath TH, Rutherford GW. Yellow fever vaccine for patients with HIV infection. Cochrane Database Syst Rev. 2014;(1):CD010929.Полный текст  Аннотация

29. Nascimento Silva JR, Camacho LA, Siqueira MM, et al; Collaborative Group for the Study of Yellow Fever Vaccines. Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella. Vaccine. 2011;29:6327-6334. Аннотация

30. Medicines and Healthcare products Regulatory Agency. Yellow fever vaccine: stronger precautions in people with weakened immunity and in those aged 60 years or older. November 2019 [internet publication].Полный текст

31. Mirzaian E, Durham MJ, Hess K, et al. Mosquito-borne illnesses in travelers: a review of risk and prevention. Pharmacotherapy. 2010;30:1031-1043. Аннотация

32. Pan American Health Organization; World Health Organization. Laboratory diagnosis of yellow fever virus infection. September 2018 [internet publication].Полный текст

33. Drosten C, Göttig S, Schilling S, et al. Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol. 2002;40:2323-2330.Полный текст  Аннотация

34. Domingo C, Patel P, Yillah J, et al. Advanced yellow fever virus genome detection in point-of-care facilities and reference laboratories. J Clin Microbiol. 2012;50:4054-4060. Аннотация

35. World Health Organization. CDC and WHO launch trial version of a new ELISA: a kit, simpler and faster to perform. July 2018 [internet publication].

36. World Health Organization.Yellow fever: case definitions for public health surveillance. May 2015 [internet publication].Полный текст

37. Centers for Disease Control and Prevention. National Notifiable Diseases Surveillance System (NNDSS): yellow fever - 1997 case definition. 1997 [internet publication].Полный текст

38. Monath TP. Treatment of yellow fever. Antiviral Res. 2008;78:116-124. Аннотация

39. Huggins JW. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug. Rev Infect Dis. 1989;11(suppl 4):S750-S761. Аннотация

40. Arroyo JI, Apperson SA, Cropp CB, et al. Effect of human gamma interferon on yellow fever virus infection. Am J Trop Med Hyg. 1988;38:647-650. Аннотация

41. Julander JG. Experimental therapies for yellow fever. Antiviral Res. 2013;97:169-179. Аннотация

42. Centers for Disease Control and Prevention. Adverse events associated with 17D-derived yellow fever vaccination: United States, 2001-2002. MMWR Morb Mortal Wkly Rep. 2002;51:989-993.Полный текст  Аннотация

43. Veit O, Niedrig M, Chapuis-Taillard C, et al. Immunogenicity and safety of yellow fever vaccination for 102 HIV-infected patients. Clin Infect Dis. 2009;48:659-666. Аннотация

44. ter Meulen J, Sakho M, Koulemou K, et al. Activation of the cytokine network and unfavorable outcome in patients with yellow fever. J Infect Dis. 2004;190:1821-1827.Полный текст  Аннотация

45. Marianneau P, Georges-Courbot M, Deubel V. Rarity of adverse effects after 17D yellow-fever vaccination. Lancet. 2001;358:84-85. Аннотация

46. Borio L, Inglesby T, Peters CJ, et al; Working Group on Civilian Biodefense. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA. 2002;287:2391-2405. Аннотация

47. Bossi P, Tegnell A, Baka A, et al. Bichat guidelines for the clinical management of haemorrhagic fever viruses and bioterrorism-related haemorrhagic fever viruses. Euro Surveill. 2004;9:E11-E12.Полный текст  Аннотация

Использование этого контента попадает под действие нашего заявления об отказе от ответственности